Is GOSS undervalued or overvalued?
As of 2025-03-16, the Intrinsic Value of Gossamer Bio Inc (GOSS) is -1.58 USD. This GOSS valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.45 USD, the upside of Gossamer Bio Inc is -209.03%. This means that GOSS is overvalued by 209.03%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.58 - -1.58 | -1.58 | -209.03% |
| P/E | (3.13) - (7.28) | (5.04) | -447.8% |
| DDM - Stable | (4.02) - (74.30) | (39.16) | -2800.6% |
| DDM - Multi | (0.74) - (10.55) | (1.37) | -194.8% |
| Market Cap (mil) | 328.57 |
| Beta | 1.20 |
| Outstanding shares (mil) | 226.60 |
| Enterprise Value (mil) | 497.39 |
| Market risk premium | 4.60% |
| Cost of Equity | 6.95% |
| Cost of Debt | 5.00% |
| WACC | 5.67% |